The ability to selectively induce apoptosis in tumour cells without affecting healthy cells makes TRAIL a vital module in the field of cancer treatment,3 including wide utilization in the treatment of glioma in the CNS.5, 6. The gene discussed is TNFSF10; the disease is central nervous system cancer.